Pro Pharma Announces New Medical Specialty Analytical Report

CANOGA PARK, Calif. - May 12, 2016 - PRLog -- Pro Pharma Pharmaceutical Consultants, Inc. is pleased to announce a new addition to their analytical reports: Medical Specialty Analyses.  This innovative report combines integrated datasets of medical, pharmacy, laboratory, genomics and enrollment to illustrate the full picture of the medical benefit performance.

Specialty data analytics is not new to Pro Pharma: health plans, government entities and self-insured employers have long had the utmost interest in integrated datasets, and most particularly medical analyses.

"Pro Pharma has been analyzing clinical therapeutics across medical and pharmacy benefits for many years," states Carol Stern, CEO.  Pro Pharma's latest specialty analytics provide an incomparable view of analytical reporting accessible via secure cloud both from desktop and mobile devices.  According to Dr. Craig Stern, President, "This approach allows benefits, financial and clinical managers the ability to "drill down" from a very high level of analytical reporting, to a detailed view, including, but not limited, to the following:"

-Total Specialty Medication Spend Across All Locations of Service

-Comparative Usage, Cost, and Utilization

-Cost Accounting, Discounting And Pricing Comps for Every Penny Spent

-Pre and Post Authorization Evaluations, Testing and Validation of All Claims Against Approved Diagnoses, FDA Labeling, Days' Supply and Dosing Standards

-Compliance Testing of Claims Validity and Completeness

-Location of Service Optimization - Centers of Excellence and Best-In-Class Comparisons

-Evaluation of Outcomes of Various Therapies - Adverse Drug Reaction, Drug-Induced Disease Risk Profiles, Compliance, Drug Holiday Evaluations, and Genomics Testing

Pro Pharma analyses are directed to optimizing management and oversight of specialty medications to meet state and federal regulatory requirements.  From enterprise to patient-specific issues, Pro Pharma's analytics provide all of the tools payers require to manage this demanding area of therapeutics.

Following Claim Adjudication Rules and Targeting Best Practices Leads to Significant Cost Savings


ABOUT PRO PHARMA

PRO PHARMA is a multi-service, woman owned, privately held consulting firm offering a vast portfolio of services to public and private entities including self-insured employers, Taft Hartley Trusts and unions, public employers, for-profit hospitals and integrated health networks, health care insurance companies, worker's compensation insurers, small-to-medium sized HMO's, and physician groups.

As a primary service to plan sponsors for achieving below trend results, PRO PHARMA provides an integrated program of administrative process improvements, clinical quality oversight, and provider/member education.

PRO PHARMA's Consulting services are grounded in the use of data and the communication of that information to define benefit trends, drivers and other analytical indicators.   PRO PHARMA markets Biotech Modeling™, Invoice Screening™, Quality Management Program™, and Treatment Calendar™. The Company directly markets its products in the U.S. and collaborates with partners to reach international markets.

For more information about PRO PHARMA, please visit http://www.propharmaconsultants.com.